Showing results (431-440 of 463) with videos related to
Sort By:
Pageof 47
Nature Medicine|December 7, 2021
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trialJason Gotlib, Andreas Reiter, Deepti H Radia, et al.Nature|May 13, 2011
Quantum annealing with manufactured spinsM W Johnson, M H S Amin, S Gildert, et al.Acta Haematologica|March 5, 2025
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia VeraJohn Mascarenhas, Prithviraj Bose, Christopher Hillis, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 16, 2026
De Novo Aortic Insufficiency and Its Progression in Patients on Microaxial Flow Pump Support Before Durable Left Ventricular Assist DeviceBoaz Elad, Kyung T Oh, Daniel Oren, et al.Clinical Transplantation|October 18, 2024
Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ TransplantsCathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, et al.Science (New York, N.Y.)|July 14, 2018
Phase transitions in a programmable quantum spin glass simulatorR Harris, Y Sato, A J Berkley, et al.JACC. Advances|April 22, 2026
Comparison of Microcirculation in Chronic Heart Failure, Cardiogenic Shock, LVAD, and Heart TransplantationJulia Baranowska, Andrea Fernandez Valledor, Cathrine M Moeller, et al.Nature Communications|January 17, 2025
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemiaTim Kong, Angelo B A Laranjeira, Christopher T Letson, et al.Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Clinical Utility of the Molecular Microscope Diagnostic System in a Real-World Transplant Cohort: Moving Towards a New ParadigmAndrea Fernandez Valledor, Cathrine M Moeller, Gal Rubinstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jason Gotlib, Michael M N Deininger, et al.Pageof 47